Skip to main content

Table 4 Multivariate survival analysis of gene mutation

From: Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma

Variable

B

SE

Pvalues

Exp(B)

95%CI

TP53

−0.119

1.084

0.913

0.888

0.106–7.438

PKD1

0.782

0.745

0.294

2.185

0.507–9.416

THADA

0.486

0.738

0.510

1.626

0.383–6.908

RB1 single copy deletion

−0.659

1.073

0.539

0.518

0.063–4.236

KRAS

1.779

0.839

0.034a

5.921

1.143–30.64

PIK3CA

−0.085

0.738

0.908

0.918

0.216–3.902

EGFR

−0.782

1.074

0.467

0.458

0.056–3.756

NF1

−3.259

4.561

0.475

0.038

0.00–293.04

PTCH1

1.285

0.871

0.140

3.616

0.655–19.96

BRCA1

9.870

35.918

0.783

19,334.66

5.165E−27–7.238E + 34

ARID1A

−1.351

1.077

0.210

0.259

0.031–2.136

MTOR

−0.443

0.828

0.593

0.642

0.127–3.255

CREBBP

0.495

1.099

0.652

1.641

0.190–14.140

ARID2

1.142

1.156

0.323

3.134

0.325–30.215

ALK

2.350

1.415

0.097

10.488

0.656–167.810

CDK12

−3.259

4.561

0.475

0.038

0.000–293.024

EMLA4-ALKfusion

0.446

1.073

0.677

1.562

0.191–12.798

  1. ap < 0.05